Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Beetroot juice may boost aging brain blood flow

NCT ID NCT03617302

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small, early study tested whether drinking beetroot juice (which is rich in natural nitrates) could improve artery stiffness and brain blood vessel function in adults aged 50 to 79. Sixteen participants were randomly given either nitrate-rich or nitrate-depleted beetroot juice. The goal was to see if this simple dietary supplement could help slow age-related changes in blood vessels and thinking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
inorganic nitrate (from beetroot juice)
What this could lead to
If it works, this could point toward a simple dietary supplement to support blood vessel health and thinking as we age.
What could go wrong
This is a very small, early-phase study with only 16 people. Results may not apply to everyone, and the effect may be too small to matter in daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Participants

16 people

The number who actually took part.

Started

Nov 2018

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 79 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 50-79 years * Cognitively healthy, having mild cognitive impairment * Able to undergo cardiovascular testing procedures including fasting overnight and holding selected morning medication doses. * Ability to understand and willingness to sign a written informed consent document. * Ability to lie comfortably for up to 90 minutes * Women only: Post-menopausal Exclusion Criteria: * Current or history of cardiovascular disease disease (heart attack, stroke, heart failure, cardiomyopathy or peripheral artery disease, heart angioplasty/stent or bypass surgery, valve replacement, carotid endarterectomy, heart transplant. * Medical history of stroke or other neurological disorder or systemic illness that could potentially affect cognition or brain function (outside of a diagnosis of Mild Cognitive impairment, Alzheimer's Disease) or could affect their safety or comfort while undergoing the imaging or cardiovascular studies. * Subjects with evidence of cardiovascular disease at baseline or during the exercise test (evidence of myocardial infarction, abnormal cardiac arrhythmia, myocardial ischemia, conduction delays, \>1mm S-T segment depression or elevation; \>3 beat ventricular tachycardia; atrial fibrillation) will be excluded from the study. * Wilson's disease, hemochromatosis * Individuals taking clonidine or other short-acting beta blocker * Resting blood pressure \> 200/ 110 mmHg or systolic \<90 mmHg * Medical history of chronic major psychiatric or current diagnosis of major psychiatric disease (other than dementia). * Systemic illness or neurological disorder potentially affecting cognition or cerebral blood flow other than mild cognitive impairment * Unable to provide informed consent due to cognitive impairment * Currently taking medications that may affect cerebral blood flow (e.g. papaverine, indomethacin, acetazolamide, etc) or efficacy of beetroot juice (proton pump inhibitors) * Current clinically abnormal thyroid function not adequately regulated by thyroid hormone supplementation or medication. * Allergic to beets * Current tobacco user or history of tobacco use within the past 3 months (cigarettes, cigars, chewing tobacco, hookah, electronic cigarettes) or living with someone who smokes/has smoked in the past 3 months. * Current diagnosis of insulin-dependent diabetes (Type I or insulin dependent Type II) * Current diagnosis of chronic obstructive lung disease, cystic fibrosis, emphysema, chronic bronchitis * History of renal failure, dialysis or kidney transplant * Current diagnosis or history of liver disease or HIV/AIDS, or cancer (other than non-melanoma skin cancers). * Current diagnosis or history of rheumatoid arthritis, systemic lupus erythematosus, Wegener's granulomatosis * Vulnerable populations (prisoners, etc) will not be eligible. * Unwillingness to wash out from a vitamin or dietary supplement regime prior to enrollment and maintain throughout the duration of the study. * Inability to comply with experimental instructions. * Uncontrolled intercurrent illness that would limit compliance with study requirements per investigator. * Inability to fast or hold morning medications doses until after testing is complete. * Hormone replacement use within the past 6 months * Currently enrolled in another study using an study medication, supplement, device or intervention.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases Cognitive Dysfunction hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Iowa

    Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.